Psychedelic Business News Spotlight: January 15, 2021
This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
About Jill Ettinger
Jill Ettinger is a Los Angeles-based writer and editor immersed in digital publishing and storytelling with a focus on the global food and wellness systems and how they intersect with our cultural traditions, ethics, and politics. Her work has been featured in The Huffington Post, MTV, and the Village Voice.
Entries by
Is America Ready for Psilocybin Mushroom Retreats?
With Oregon’s recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that mean for mental health treatment?
Psychedelic Business News Spotlight: January 08, 2021
This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
NeonMind Takes Psilocybin Therapy Public
NeonMind is the latest psychedelic company to go public. It’s the first to launch on the Canadian Stock Exchange in 2021.
7 Psychedelic Trend Predictions for 2021
The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.
Psychedelic Business News Spotlight: December 17, 2020
The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson’s, and more business news.
Interview with Daniel Carcillo
December 16, 2020 /0 Comments/by Jill EttingerFirst-Ever DMT Trials for Depression Approved in UK
The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.
Psychedelic Business News Spotlight: December 10, 2020
This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.
Interview with Kelli Foulkrod
December 9, 2020 /0 Comments/by Jill EttingerPsychedelic Spotlight
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
